- $17.75bn
- $21.07bn
- $4.25bn
- 75
- 38
- 100
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,988 | 3,317 | 3,816 | 4,091 | 4,254 |
Cost of Revenue | |||||
Gross Profit | 1,961 | 2,158 | 2,444 | 2,607 | 2,681 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,800 | 3,045 | 3,434 | 3,596 | 3,711 |
Operating Profit | 188 | 272 | 382 | 495 | 544 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 126 | -495 | 254 | 357 | 404 |
Provision for Income Taxes | |||||
Net Income After Taxes | 138 | -494 | 243 | 353 | 1,376 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 137 | -495 | 242 | 352 | 1,375 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 137 | -495 | 242 | 352 | 1,375 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.872 | -2.9 | 1.41 | 2.3 | 9.54 |